On Monday 4th November 2024, investors and market participants can expect the release of Castle Biosciences (NASDAQ: CSTL) third quarter financial results. This crucial announcement will be made after market close.
Financial experts on Wall Street anticipate that the organization is set to announce an estimated $0.06 loss per share for the quarter. Furthermore, the company is expected to disclose a total revenue of $79.84 million for this specific period.
Examining the corresponding quarter from the previous year, the company's earnings report unveiled a loss of $0.26 per share. This number was attributed to the company's total revenue, which settled at an impressive $61.49 million during the same period.
The forecasts for the company's annual performance have been disclosed by Wall Street analysts, with an estimated total revenue of $297.99 million. In addition, they anticipate the company to report loss of $0.55 per share for the fiscal year.
In addition, The firm will review the third quarter financial results on 4th November 2024 at 04:30 PM eastern time, in a conference call with public.
During Friday's trading, Castle Biosciences (CSTL) shares reached a low of $32.58 and a high of $35.39, along with a total volume of 808.60 thousand shares. The stock ended the regular trading session at $33.15, indicating fall of 4.38 percent.
